North America clinical nutrition market is expected to grow by 5.52% annually in the forecast period and reach $20.39 billion by 2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic.
Highlighted with 28 tables and 66 figures, this 124-page report North America Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country.

Based on Substrate, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Carbohydrates
Lipids
Proteins & Amino Acids
Water & Electrolyte
Dietary Fiber
Antioxidants
Other Substrates

Based on Administration Route, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Oral or Enteral Administration
Oral Nutrition Supplements
Tube Feeding
Parenteral Administration
Supplemental Parenteral Nutrition
Total Parenteral Nutrition
All-in-One System
Multiple Bottle System

Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Infant
Children
Adult
Geriatrics

Based on Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Malnutrition
Metabolic Disorders
Gastrointestinal Disorders
Cancer
Neurology
Renal Diseases
Respiratory Diseases
Other Therapeutic Areas

Based on Healthcare Setting, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Hospitals
Long-term Care Facilities (LTC)
Homecare
Inpatient Rehabilitation Facilities
Other Healthcare Settings

Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Institutional Sales
Supermarkets & Hypermarkets
Pharmacies
Drug Stores
Online Channels
Other Distribution Channels

Geographically, the following national/local markets are fully investigated:
U.S.
Canada
Mexico
For each country, detailed analysis and data for annual revenue are available for 2019-2026. The breakdown of key national markets by Administration Route, End User, and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America clinical nutrition market are assayed quantitatively and qualitatively through GMDs Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Nutrition
B Braun Melsungen Ag
BASF SE
Baxter International Inc.
Claris Lifesciences Ltd.
Fresenius Kabi Ag
Lonza Group AG
Nestle Health Science
Nutricia Ltd
Perrigo Company Plc
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)